Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2172 (LINC02172)
- Target
- LINC02172
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Non-coding RNA, Other (regulatory RNA)
01
Overview
Long intergenic non-protein coding RNA 2172 (LINC02172) is a non-coding RNA gene located on human chromosome 4[5]. It is classified as a lincRNA, belonging to a group of RNA transcripts longer than 200 nucleotides that are transcribed from intergenic regions and do not overlap annotated coding genes[5][7]. LincRNAs are thought to fine-tune gene expression, modulate chromatin architecture, regulate transcription, or carry out other regulatory functions, often with tissue specificity[7]. Most lincRNAs, including LINC02172, have not been functionally characterized in detail. There is no evidence to suggest that LINC02172 encodes a protein or acts as a receptor, enzyme, or other classical therapeutic target[1][5][7].
- Other names
- LINC02172Long intergenic non-protein coding RNA 2172
02
Mechanism of action
Not applicable. As no drugs target this molecule, there are no characterized mechanisms of drug action
03
Biological functions
Transcription regulationChromatin remodelingFine-tuning of gene expression (often near neighboring genes)
04
Disease associations
Other (possible gene regulatory involvement in disease not specific to a well-defined mechanism or major therapeutic classification, based on general lincRNA roles)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2172 (LINC02172).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2172 (LINC02172).